Search

Your search keyword '"Powis, Zoe"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Powis, Zoe" Remove constraint Author: "Powis, Zoe"
46 results on '"Powis, Zoe"'

Search Results

1. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann‐Steiner syndrome

2. Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients.

3. Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy

4. A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome

6. Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition

9. Recurrent de novo missense variants across multiple histone H4 genes underlie a neurodevelopmental syndrome.

10. De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability

12. Recurrent de novo missense variants across multiple histone H4 genes underlie a neurodevelopmental syndrome

14. De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability

15. De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability.

16. ATP1A2-and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria

18. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner Syndrome

20. Retrospective review of genetic testing for inherited bone marrow failure syndromes

21. Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next‐generation sequencing

22. De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder

23. Clinical spectrum of STX1B-related epileptic disorders

24. De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder

25. MAGEL2 ‐related disorders: A study and case series

27. De novocoding variants in the AGO1gene cause a neurodevelopmental disorder with intellectual disability

30. Molecular diagnosis for neurodevelopmental disorders-an overview of multi-gene panels and whole exome sequencing (P3.211)

36. A second cohort of CHD3patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome

43. ATP1A2- and ATP1A3- associated early profound epileptic encephalopathy and polymicrogyria

45. Clinical features and genotype-phenotype correlations in epilepsy patients with de novo DYNC1H1 variants.

46. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.

Catalog

Books, media, physical & digital resources